Bank Julius Baer & Co
CLVS

Bank Julius Baer & Co’s Clovis Oncology, Inc. CLVS Stock Holding History

Bank Julius Baer & Co’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,000
Closed -$18K – 916
2021
Q3 		$18K Buy
+4,000
New +$19.3K ﹤0.01% 750
2021
Q1 		– Sell
-5,000
Closed -$24K – 918
2020
Q4 		$24K Sell
5,000
-5,000
-50% -$25.3K ﹤0.01% 737
2020
Q3 		$58K Buy
10,000
+2,500
+33% +$15K ﹤0.01% 594
2020
Q2 		$51K Buy
7,500
+2,422
+48% +$18.3K ﹤0.01% 565
2020
Q1 		$32K Buy
+5,078
New +$40.7K ﹤0.01% 567

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank Julius Baer & Co's CLVS Position: Q4 2021 in Review

Bank Julius Baer & Co sold out of Clovis Oncology, Inc. (CLVS) in Q4 2021, closing a stake of 4,000 shares — an estimated $18K sold.

Bank Julius Baer & Co first reported a position in CLVS in Q1 2020 and held it in 5 quarters. The position peaked at $58K in Q3 2020. 153 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.

  • Bank Julius Baer & Co reported no remaining Clovis Oncology, Inc. position as of Q4 2021 after selling out during the quarter.
  • Bank Julius Baer & Co sold 4,000 Clovis Oncology, Inc. shares in Q4 2021, an estimated $18K.
  • Bank Julius Baer & Co first reported a position in Clovis Oncology, Inc. in Q1 2020 and held it in 5 quarters.
  • Bank Julius Baer & Co's Clovis Oncology, Inc. position peaked at $58K in Q3 2020.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.

Based on Bank Julius Baer & Co's 13F filing for Q4 2021, filed 15 Feb 2022.